{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:09:06Z","timestamp":1747159746374,"version":"3.40.5"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ejphar.2018.12.008","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T17:53:39Z","timestamp":1544118819000},"page":"253-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Antinociception by fluoro-loxoprofen, a novel non-steroidal anti-inflammatory drug with less ulcerogenic effects, in rat models of inflammatory pain"],"prefix":"10.1016","volume":"844","author":[{"given":"Teita","family":"Asano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1893-0751","authenticated-orcid":false,"given":"Ken-ichiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Suemasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Aida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marika","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Mizushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuko","family":"Takenaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.12.008_bib1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000211713","article-title":"A questionnaire-based survey on the prescription of non-steroidal anti-inflammatory drugs by physicians in East Asian countries in 2007","volume":"79","author":"Arakawa","year":"2009","journal-title":"Digestion"},{"key":"10.1016\/j.ejphar.2018.12.008_bib2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.cgh.2009.03.015","article-title":"Proton pump inhibitors for gastroduodenal damage related to nonsteroidal anti-inflammatory drugs or aspirin: twelve important questions for clinical practice","volume":"7","author":"Arora","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2018.12.008_bib3","doi-asserted-by":"crossref","first-page":"356","DOI":"10.2519\/jospt.2005.35.6.356","article-title":"Pharmacology in rehabilitation: nonsteroidal anti-inflammatory agents","volume":"35","author":"Biederman","year":"2005","journal-title":"J. Orthop. Sports Phys. Ther."},{"key":"10.1016\/j.ejphar.2018.12.008_bib4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/JPR.S75160","article-title":"New insights into the use of currently available non-steroidal anti-inflammatory drugs","volume":"8","author":"Brune","year":"2015","journal-title":"J. Pain. Res."},{"key":"10.1016\/j.ejphar.2018.12.008_bib5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrrheum.2010.141","article-title":"Using pharmacokinetic principles to optimize pain therapy","volume":"6","author":"Brune","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"issue":"Suppl. 3","key":"10.1016\/j.ejphar.2018.12.008_bib6","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar4174","article-title":"Use of NSAIDs in treating patients with arthritis","volume":"15","author":"Crofford","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejphar.2018.12.008_bib7","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/bja\/66.6.703","article-title":"Non-steroidal anti-inflammatory drugs: rationale for use in severe postoperative pain","volume":"66","author":"Dahl","year":"1991","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejphar.2018.12.008_bib8","first-page":"CD004768","article-title":"Single dose oral diclofenac for acute postoperative pain in adults","author":"Derry","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2018.12.008_bib9","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/MCG.0000000000000372","article-title":"Celecoxib monotherapy maintained small intestinal mucosa better compared with loxoprofen plus lansoprazole treatment: a double-blind, randomized, controlled trial","volume":"50","author":"Fujimori","year":"2016","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.ejphar.2018.12.008_bib10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1211\/jpp.61.05.0009","article-title":"The importance of brain PGE2 inhibition versus paw PGE2 inhibition as a mechanism for the separation of analgesic and antipyretic effects of lornoxicam in rats with paw inflammation","volume":"61","author":"Futaki","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.12.008_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1542-3565(04)00603-2","article-title":"Visible small-intestinal mucosal injury in chronic NSAID users","volume":"3","author":"Graham","year":"2005","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2018.12.008_bib12","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s40261-016-0440-9","article-title":"Loxoprofen: a review in pain and inflammation","volume":"36","author":"Greig","year":"2016","journal-title":"Clin. Drug. Investig."},{"key":"10.1016\/j.ejphar.2018.12.008_bib13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.18433\/J3VW2F","article-title":"Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications","volume":"16","author":"Harirforoosh","year":"2013","journal-title":"J. Pharm. Pharm. Sci."},{"year":"2009","series-title":"Fluorine in Medicinal Chemistry and Chemical Biology","author":"Iwao","key":"10.1016\/j.ejphar.2018.12.008_bib14"},{"key":"10.1016\/j.ejphar.2018.12.008_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1440-1746.1995.tb01053.x","article-title":"Effects of loxoprofen sodium, a newly synthesized non-steroidal anti-inflammatory drug, and indomethacin on gastric mucosal haemodynamics in the human","volume":"10","author":"Kawano","year":"1995","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2018.12.008_bib16","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/sj.bjp.0705310","article-title":"Calcineurin inhibitors exert rapid reduction of inflammatory pain in rat adjuvant-induced arthritis","volume":"139","author":"Magari","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.12.008_bib17","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0149-2918(02)80059-5","article-title":"A comparison of rofecoxib versus celecoxib in treating pain after dental surgery: a single-center, randomized, double-blind, placebo- and active-comparator-controlled, parallel-group, single-dose study using the dental impaction pain model","volume":"24","author":"Malmstrom","year":"2002","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejphar.2018.12.008_bib18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/bdd.319","article-title":"Pharmacological and pharmacokinetic evaluation of celecoxib prodrugs in rats","volume":"23","author":"Mamidi","year":"2002","journal-title":"Biopharm. Drug. Dispos."},{"key":"10.1016\/j.ejphar.2018.12.008_bib19","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/art.27412","article-title":"Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding","volume":"62","author":"Masso Gonzalez","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2018.12.008_bib20","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1097\/MJT.0000000000000123","article-title":"Evolving therapeutic strategies to improve nonsteroidal anti-inflammatory drug safety","volume":"22","author":"McCarberg","year":"2015","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.ejphar.2018.12.008_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pain.2013.08.013","article-title":"Faster, higher, stronger? Evidence for formulation and efficacy for ibuprofen in acute pain","volume":"155","author":"Moore","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2018.12.008_bib22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1124\/jpet.103.050781","article-title":"Allodynia and hyperalgesia in adjuvant-induced arthritic rats: time course of progression and efficacy of analgesics","volume":"306","author":"Nagakura","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.12.008_bib23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/PL00012435","article-title":"Effect of the selective COX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation","volume":"51","author":"Pinheiro","year":"2002","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejphar.2018.12.008_bib24","first-page":"409","article-title":"A method for measurement of analgesic activity on inflamed tissue","volume":"111","author":"Randall","year":"1957","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.ejphar.2018.12.008_bib25","doi-asserted-by":"crossref","first-page":"81s","DOI":"10.18433\/J3T886","article-title":"Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond","volume":"11","author":"Rao","year":"2008","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejphar.2018.12.008_bib26","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/apt.12174","article-title":"Comparison of gastroduodenal ulcer incidence in healthy Japanese subjects taking celecoxib or loxoprofen evaluated by endoscopy: a placebo-controlled, double-blind 2-week study","volume":"37","author":"Sakamoto","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2018.12.008_bib27","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00776-015-0726-4","article-title":"Loxoprofen sodium and celecoxib for postoperative pain in patients after spinal surgery: a randomized comparative study","volume":"20","author":"Sekiguchi","year":"2015","journal-title":"J. Orthop. Sci."},{"issue":"Suppl 3","key":"10.1016\/j.ejphar.2018.12.008_bib28","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar4175","article-title":"Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage","volume":"15","author":"Sostres","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejphar.2018.12.008_bib29","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.bcp.2012.09.016","article-title":"Identification of a unique nsaid, fluoro-loxoprofen with gastroprotective activity","volume":"84","author":"Suemasu","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.12.008_bib30","first-page":"775","article-title":"Anti-inflammatory effects of selective COX-2 inhibitors","volume":"56","author":"Suleyman","year":"2004","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.12.008_bib31","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1053\/j.gastro.2008.01.010","article-title":"The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs","volume":"134","author":"Targownik","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2018.12.008_bib32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejim.2015.03.008","article-title":"Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: a systematic review and meta-analysis of observational studies","volume":"26","author":"Ungprasert","year":"2015","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.ejphar.2018.12.008_bib33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejphar.2007.08.034","article-title":"Preclinical pharmacology profile of CS-706, a novel cyclooxygenase-2 selective inhibitor, with potent antinociceptive and anti-inflammatory effects","volume":"578","author":"Ushiyama","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.12.008_bib34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.14336\/AD.2017.0306","article-title":"A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly","volume":"9","author":"Wongrakpanich","year":"2018","journal-title":"Aging Dis."},{"key":"10.1016\/j.ejphar.2018.12.008_bib35","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1248\/bpb.33.398","article-title":"Low direct cytotoxicity of loxoprofen on gastric mucosal cells","volume":"33","author":"Yamakawa","year":"2010","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejphar.2018.12.008_bib36","doi-asserted-by":"crossref","first-page":"7879","DOI":"10.1021\/jm101116s","article-title":"Properties and synthesis of 2-{2-fluoro (or bromo)-4-[(2-oxocyclopentyl)methyl]phenyl}propanoic acid: nonsteroidal anti-inflammatory drugs with low membrane permeabilizing and gastric lesion-producing activities","volume":"53","author":"Yamakawa","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2018.12.008_bib37","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1021\/jm300049g","article-title":"Synthesis and biological evaluation of derivatives of 2-{2-fluoro-4-[(2-oxocyclopentyl)methyl]phenyl}propanoic acid: nonsteroidal anti-inflammatory drugs with low gastric ulcerogenic activity","volume":"55","author":"Yamakawa","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2018.12.008_bib38","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2133\/dmpk.DMPK-12-RG-050","article-title":"Comparison of pharmacokinetics between loxoprofen and its derivative with lower ulcerogenic activity, fluoro-loxoprofen","volume":"28","author":"Yamakawa","year":"2013","journal-title":"Drug. Metab. Pharmacokinet."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918307040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918307040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:27:03Z","timestamp":1605572823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918307040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":38,"alternative-id":["S0014299918307040"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.12.008","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antinociception by fluoro-loxoprofen, a novel non-steroidal anti-inflammatory drug with less ulcerogenic effects, in rat models of inflammatory pain","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}